 |
|
Rosti Group (Rosti) has sold its medical packaging and beverage systems division in the Netherlands, Rosti B.V. (Rosti Nederland), to Helvoet Holding B.V. (Helvoet).
Rosti Nederland, based in Tilburg, is a plastic injection molding and contract manufacturing company active primarily in the life science sector as well as the food and beverage sector. Clients include Roche, Heineken and Delphi Bioscience.
Rosti is a leading manufacturer of high-precision plastic parts and provides related services to customers in the electrical, medical, automotive and food packaging industries.
|
The Rosti Group is an expanding international business, operating six manufacturing plants in China, India, Poland, the UK, Germany and Sweden. Rosti is owned by Nordstjernan, a Swedish family-controlled investment group.
Helvoet is internationally active in the custom-made development and high-precision production of single and assembled plastic and rubber components for the automotive and industrial industries and medical packaging market. Helvoet has operations in Hellevoetsluis (Netherlands), Lommel (Belgium) and Pune (India) with sales departments in Detroit (USA) and Singapore.
Commenting on the transaction, Börje Vernet, CEO of Rosti, said: “As part of our strategic planning for organic growth and acquisitions, we conducted a review of all the businesses in our portfolio and concluded that Rosti Nederland will be better positioned for future growth as part of an organization with a strong market position in the Benelux region. Rosti’s strategic review is now complete, with clear actions for organic growth and plans for acquisitions in our target markets and regions.”
M&A International Inc.’s members in the Netherlands, Holland Corporate Finance, and Sweden, Avantus Corporate Finance, advised Rosti on this transaction. Our members demonstrated once again how they can seamlessly support their client base by delivering professional advice in cross-border divestments. Their local expertise and knowledge were key factors that significantly contributed to maximizing value for the client.
Hans Udo Wenzel, CEO of Azelis Group, commented, “This is a significant milestone in the realization of the group’s ambition to become one of Europe’s leading specialty distributors. Brøste complements the sector-focused activities of Azelis which include food, pharma and cosmetics, veterinary, plastics, composites, rubber coatings and chemical industries. Brøste will provide us with access to additional markets in this important geographical region.”
Brøste’s CEO Jens U. Schrøder added, “Our entrepreneurial approach to doing business and our values and business vision fit very well with the Azelis culture. Day to day contacts with customers will remain the same ensuring continuity of knowledgeable local service and I believe that they, and all our other business partners, will benefit significantly from this decision to become part of Azelis.”
The company, which has been established since 1915, will continue to trade as Brøste under the current management team led by Jens Schrøder. Former owner, Peter Brøste will become a member of the Azelis Advisory Board and an investor in the Azelis Group. This latest addition to the Group takes the expected Azelis group sales in 2005 to over €820 million.
|
